BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6347789)

  • 1. [Captopril therapy in chronic congestive heart failure].
    Morgera T; Humar F; Mestroni L; Maras P; Camerini F
    G Ital Cardiol; 1983; 13(1):39-46. PubMed ID: 6347789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic and clinical effects of captopril in congestive heart failure].
    Galiè N; Magelli C; Ribani MA; Bassein L; Sanguinetti M; Magnani B
    G Ital Cardiol; 1985 Jan; 15(1):70-9. PubMed ID: 3891488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
    Le Pailleur C; Baubion N; Metzger JP; Heulin A; Vacheron A; Di Matteo J
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):700-6. PubMed ID: 6431936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and clinical effects of captopril in patients with severe congestive heart failure.
    Nigri A; Mangieri E; Martuscelli E; Danesi A; Sardella G; Berni A; Sardella F
    Cardiologia; 1989 Jun; 34(6):525-9. PubMed ID: 2676169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term treatment of severe cardiac insufficiency with captopril].
    Ohayon J; Colle JP; Ledain L; Besse P
    Ann Cardiol Angeiol (Paris); 1984; 33(4):239-44. PubMed ID: 6380382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].
    Ourbak P; Pornin M; Melanidis J; Bouziri S; Allal J; Sellier P; Maurice P
    Arch Mal Coeur Vaiss; 1984 Aug; 77(8):865-71. PubMed ID: 6435565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure.
    Franciosa JA; Leddy CL; Schwartz DE
    Z Kardiol; 1983; 72 Suppl 3():168-72. PubMed ID: 6666217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year clinical and echocardiographic follow-up of patients with congestive cardiomyopathy treated with captopril compared to placebo.
    Keren G; Pardes A; Eschar Y; Koifman B; Scherez J; Geleranter I; Laniado S
    Isr J Med Sci; 1994 Jan; 30(1):90-8. PubMed ID: 8138400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of enalapril and captopril in the treatment of chronic heart failure].
    Tjon-A-Meeuw L; Hess OM; Greminger P; Maire R; Jenni R; Krayenbuehl HP
    Z Kardiol; 1990 Jun; 79(6):429-35. PubMed ID: 2198731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute and long-term effect of captopril in severe chronic heart failure].
    Kikis D; Heck I; Stumpe KO; Esser H
    Dtsch Med Wochenschr; 1985 Apr; 110(15):583-8. PubMed ID: 2983968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic refractory cardiac insufficiency with an inhibitor of converting enzyme. Long-term results].
    Charbonnier B; Monpère C; Desveaux B; Cosnay P; Fauchier JP; Brochier M
    Ann Cardiol Angeiol (Paris); 1984; 33(4):233-7. PubMed ID: 6087714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Captopril in cardiac insufficiency. Immediate and long-term effects].
    Champoud O; Cribier A; Berland J; Moore N; Letac B
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):738-46. PubMed ID: 6433836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects].
    Figulla HR; Luig H; Nieschlag F; Kreuzer H
    Z Kardiol; 1987 Mar; 76(3):167-74. PubMed ID: 3109142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
    Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
    Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and medium term results of tailored therapy for heart failure.
    Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
    Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF; Grom E; Jähnchen E; Roskamm H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.